Development and preclinical evaluation of novel 177-lutetium nanoparticle as potential radiotherapy for solid tumors
Jan. 20, 2023
Polymeric nanoparticles selectively accumulate in solid tumors in part due to tumor-associated angiogenesis without efficient lymphatic drainage exerting an enhanced permeation and retention (EPR) effect. Many radiotherapies fail due to poor tumor cell selectivity.